PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 25323695-4 2014 The BET bromodomains (protein interaction modules that bind acetyl-lysine) have been targeted by potent small-molecule inhibitors, but these inhibitors lack selectivity for individual family members. N(alpha)-acetyllysine 60-73 delta/notch like EGF repeat containing Homo sapiens 4-7 34203690-1 2021 The 3,5-dimethylisoxazole motif has become a useful and popular acetyl-lysine mimic employed in isoxazole-containing bromodomain and extra-terminal (BET) inhibitors but may introduce the potential for bioactivations into toxic reactive metabolites. N(alpha)-acetyllysine 64-77 delta/notch like EGF repeat containing Homo sapiens 149-152 29561307-3 2018 ITH-47 is an acetyl-lysine inhibitor that displaces bromdomain 4 proteins from chromatin by competitively binding to the acetyl-lysine recognition pocket of this bromodomain and extraterminal (BET) BRD protein, thereby preventing transcription of cancer-associated genes and further cell growth. N(alpha)-acetyllysine 13-26 delta/notch like EGF repeat containing Homo sapiens 193-196 29189147-0 2018 Disrupting Acetyl-lysine Interactions: Recent Advance in the Development of BET Inhibitors. N(alpha)-acetyllysine 11-24 delta/notch like EGF repeat containing Homo sapiens 76-79 28277835-3 2017 Proof-of-principle that epigenetic readers are also relevant drug targets was provided by landmark discoveries of selective inhibitors targeting the BET family of acetyl-lysine readers. N(alpha)-acetyllysine 163-176 delta/notch like EGF repeat containing Homo sapiens 149-152 27707886-1 2017 Competitive inhibitors of acetyl-lysine binding to the bromodomains of the BET (bromodomain and extra terminal) family are being developed for the treatment of solid and hematologic malignancies. N(alpha)-acetyllysine 26-39 delta/notch like EGF repeat containing Homo sapiens 75-78 17848202-7 2007 The helix piD forms a portion of the acetyl-lysine binding site, which could be a structural characteristic of Brd2 BD2 and other BET bromodomains. N(alpha)-acetyllysine 37-50 delta/notch like EGF repeat containing Homo sapiens 130-133 23939492-0 2013 BET acetyl-lysine binding proteins control pathological cardiac hypertrophy. N(alpha)-acetyllysine 4-17 delta/notch like EGF repeat containing Homo sapiens 0-3 23939492-2 2013 JQ1, a small molecule inhibitor of bromodomain and extraterminal (BET) acetyl-lysine reader proteins, was identified in a high throughput screen designed to discover novel small molecule regulators of cardiomyocyte hypertrophy. N(alpha)-acetyllysine 71-84 delta/notch like EGF repeat containing Homo sapiens 66-69 21964340-3 2011 Here we use a global proteomic strategy to demonstrate that MLL fusions, as part of SEC and the polymerase-associated factor complex (PAFc), are associated with the BET family of acetyl-lysine recognizing, chromatin "adaptor" proteins. N(alpha)-acetyllysine 179-192 delta/notch like EGF repeat containing Homo sapiens 165-168